PMID: 11902660Mar 21, 2002Paper

Synthesis and antimicrobial activity of some new hydrazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines

Il Farmaco
Sevim RollasH Erdeniz

Abstract

A series of hydrazide hydrazones and 1,3,4-oxadiazolines of 4-fluorobenzoic acid hydrazide were prepared and evaluated as potential antimicrobial agents and were tested for their antibacterial and antifungal activities against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans. From these compounds, 4-fluorobenzoic acid[(5-nitro-2-furanyl)methylene]hydrazide (1a) showed equal activity with ceftriaxone against S. aureus. In addition, the MIC values of compounds 1c, 1d and 2a for the same strain were in the range of those reported for ceftriaxone according to NCCLS 1997.

References

Apr 1, 1990·Journal of Pharmaceutical Sciences·R KalsiS S Parmar
Sep 1, 1995·Antimicrobial Agents and Chemotherapy·F C OddsF Woestenborghs

❮ Previous
Next ❯

Citations

Dec 9, 2000·European Journal of Drug Metabolism and Pharmacokinetics·N N GülermanS Rollas
Mar 20, 2008·European Journal of Drug Metabolism and Pharmacokinetics·Bedia Koçyiğit-KaymakçioğluSevim Rollas
Dec 31, 2010·Archives of Pharmacal Research·Mohamed T Abdel-AalAhmed L Zein
Oct 7, 2011·Archives of Pharmacal Research·Yusuf ÖzkayIlhan Işıkdağ
Dec 4, 2003·European Journal of Medicinal Chemistry·S Güniz KüçükgüzelJames Stables
Nov 21, 2013·Journal of Agricultural and Food Chemistry·Paulrasu KodisundaramThirunavukkarasu Balasankar
Jan 1, 2008·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunSuchada Chantrapromma
Jan 1, 2008·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunB Kalluraya
Jan 1, 2008·Acta Crystallographica. Section E, Structure Reports Online·Chin Sing YeapHoong-Kun Fun
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunB Kalluraya
Apr 28, 2011·Acta Crystallographica. Section E, Structure Reports Online·Adailton J BortoluzziRicardo J Nunes
Jul 15, 2011·Acta Crystallographica. Section E, Structure Reports Online·Jerry P JasinskiH S Yathirajan
Nov 9, 2011·Acta Crystallographica. Section E, Structure Reports Online·A S DayanandaC R Raju
Jan 4, 2013·Acta Crystallographica. Section E, Structure Reports Online·Angel MendozaMarcos Flores-Alamo
Jul 1, 2009·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Parameswaran ManojkumarGopalakrishnan Subbuchettiar
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Jia Hao GohB Kalluraya
Jan 1, 2008·Acta Crystallographica. Section E, Structure Reports Online·Xiao-Yang Qiu
Jan 1, 2008·Acta Crystallographica. Section E, Structure Reports Online·Xiao-Yang Qiu
Jan 1, 2008·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunB Kalluraya
Nov 8, 2011·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunBalakrishna Kalluraya
Jan 1, 2008·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunSuchada Chantrapromma
Jan 1, 2008·Acta Crystallographica. Section E, Structure Reports Online·Chun-Lin Du
Jan 1, 2010·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunSuresh P Nayak
Feb 22, 2012·Acta Crystallographica. Section E, Structure Reports Online·Angel MendozaVladimir Carranza
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunB Kalluraya
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunB Kalluraya
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Xiao-Yang Qiu
Sep 21, 2013·Acta Crystallographica. Section E, Structure Reports Online·Ruth Meléndrez-LuévanoPedro Conde-Sánchez
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Mariusz MojzychPrzemysław Kalicki
Jan 1, 2008·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunB Kalluraya
Apr 23, 2014·Bioorganic & Medicinal Chemistry·Rodrigo Rocha ZorziLeoberto Costa Tavares
Jan 1, 2012·International Journal of Medicinal Chemistry·Seranthimata SamshuddinNalilu Suchetha Kumari
Oct 11, 2013·Acta Crystallographica. Section E, Structure Reports Online·B C ManjunathN K Lokanath
Aug 20, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ayman El-FahamHoong-Kun Fun
Feb 13, 2016·Acta Crystallographica. Section E, Crystallographic Communications·Shaaban K MohamedMustafa R Albayati
Dec 2, 2009·Bioorganic & Medicinal Chemistry·Olayinka O AjaniDavid A Akinpelu
Sep 4, 2015·Chemical & Pharmaceutical Bulletin·Rafat Milad Mohareb, Nadia Youssef Megally Abdo
May 19, 2012·Acta Crystallographica. Section E, Structure Reports Online·Shaaban K MohamedHerman Potgieter
Aug 21, 2012·Acta Crystallographica. Section E, Structure Reports Online·Shaaban K MohamedAntar A Abdelhamid
Aug 22, 2006·European Journal of Medicinal Chemistry·Koçyiğit-Kaymakçioğlu BediaAnatholy Dimoglo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.